We are live on
!
Find out more
EVOK
Evoke Pharma
EVOK
EVOK
Delisted
EVOK was delisted on the 16th of December, 2025.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OM
1
Opaleye Management
Boston,
Massachusetts
| $1.96M | +$2.31M | +1,621 | New |
|
|
SC
2
Sophrosyne Capital
New York
| $411K | +$485K | +340 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $395K | +$110K | +77 | +31% |
|
4
Bank of America
Charlotte,
North Carolina
| $281K | -$9.98K | -7 | -3% |
|
|
LP
5
LMR Partners
London,
United Kingdom
| $199K | +$237K | +166 | New |
|
|
TC
6
TFS Capital
West Chester,
Pennsylvania
| $88K | -$41.4K | -29 | -28% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $85K | +$101K | +71 | New |
|
8
Citigroup
New York
| $17K | +$20K | +14 | New |
|
|
U
9
UBS
Zurich,
Switzerland
| $11K | +$4.28K | +3 | +50% |
|
10
Morgan Stanley
New York
| $4K | -$178K | -125 | -98% |
|
|
ARTA
11
A.R.T. Advisors
New York
| – | -$83K | -78 | Closed |
|